Education
About Us
Working with TipRanks
Follow Us
Aerovate Therapeutics (AVTE)
NASDAQ:AVTE
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -96.00K | $ -68.00K | $ -15.00K | $ -1.00K |
| Operating Income | $ -74.60M | $ -81.41M | $ -53.24M | $ -23.02M | $ -8.89M |
| EBITDA | $ -74.31M | $ -81.31M | $ -53.17M | $ -23.01M | $ -8.89M |
| Net Income | $ -69.63M | $ -75.52M | $ -51.51M | $ -22.96M | $ -9.04M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 78.62M | $ 122.44M | $ 129.22M | $ 167.38M | $ 4.57M |
| Total Assets | $ 80.33M | $ 127.42M | $ 135.30M | $ 175.36M | $ 4.71M |
| Total Debt | $ 417.00K | $ 675.00K | $ 1.09M | $ 574.00K | $ 0.00 |
| Net Debt | $ -33.33M | $ -22.82M | $ -21.31M | $ -53.62M | $ -4.57M |
| Total Liabilities | $ 3.90M | $ 17.96M | $ 8.56M | $ 2.94M | $ 18.06M |
| Stockholders' Equity | $ 76.43M | $ 109.46M | $ 126.74M | $ 172.42M | $ -13.34M |
| Cash Flow | |||||
| Free Cash Flow | $ -71.20M | $ -56.92M | $ -39.32M | $ -27.58M | $ -7.86M |
| Operating Cash Flow | $ -71.20M | $ -56.78M | $ -39.12M | $ -27.40M | $ -7.86M |
| Investing Cash Flow | $ 56.03M | $ 11.88M | $ 6.93M | $ -113.43M | $ 0.00 |
| Financing Cash Flow | $ 25.43M | $ 46.00M | $ 396.00K | $ 190.46M | $ 8.92M |